title: Correction: Circulating miR-19a and miR-205 in Serum May Predict the Sensitivity of Luminal A Subtype of Breast Cancer Patients to Neoadjuvant Chemotherapy with Epirubicin Plus Paclitaxel.
authors: Qian
authors: Q
authors: Li
authors: Mei
authors: M
authors: Liu
authors: Fei
authors: F
authors: Ma
authors: Yang
authors: Y
authors: Luo
authors: Ruigang
authors: R
authors: Cai
authors: Liming
authors: L
authors: Wang
authors: Ningzhi
authors: N
authors: Xu
authors: Binghe
authors: B
authors: Xu